HCM
SCMP

Herndon Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Herndon Capital Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$5K Buy
+458
New +$4.67K ﹤0.01% 186

Other funds holding SCMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Herndon Capital Management's SCMP Position: Q2 2017 in Review

Herndon Capital Management opened a new position in Sucampo Pharmaceuticals, Inc. (SCMP) in Q2 2017: 458 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #186 among its holdings.

167 funds tracked by Wall St. Rank hold SCMP as of Q2 2017.

  • Herndon Capital Management held 458 shares of Sucampo Pharmaceuticals, Inc. worth $5K as of Q2 2017.
  • Sucampo Pharmaceuticals, Inc. was a new Herndon Capital Management position in Q2 2017.
  • Sucampo Pharmaceuticals, Inc. made up ﹤0.01% of Herndon Capital Management's portfolio in Q2 2017, its #186 holding.
  • 167 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q2 2017.

Based on Herndon Capital Management's 13F filing for Q2 2017, filed 4 Aug 2017.